NVIDIA Forecast, price target & analysts
NVIDIA Target price 2025 - Analyst rating & recommendation
NVIDIA Classifications & Recommendation:
NVIDIA Price Target
| Target Price | $171.67 |
| Price | $141.97 |
| Potential | 20.92% |
| Number of Estimates | 54 |
| 54 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $171.67. This is 20.92% higher than the current stock price. The highest price target is $210.00 47.92% , the lowest is $100.00 29.56% . | |
| A rating was issued by 68 analysts: 61 Analysts recommend NVIDIA to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 20.92% . Most analysts recommend the NVIDIA stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
57 Analysts have issued a sales forecast NVIDIA 2026 . The average NVIDIA sales estimate is $200b . This is 35.00% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $228b 53.52% , the lowest is $184b 23.88% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $130b | 114.20% |
|---|---|---|
| 2026 | $200b | 53.63% |
| 2027 | $251b | 25.18% |
| 2028 | $287b | 14.43% |
| 2029 | $313b | 9.12% |
| 2030 | $324b | 3.34% |
19 Analysts have issued an NVIDIA EBITDA forecast 2026. The average NVIDIA EBITDA estimate is $123b . This is 38.41% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $134b 50.91% , the lowest is $108b 21.02% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $83.9b | 139.06% |
|---|---|---|
| 2026 | $123b | 46.57% |
| 2027 | $163b | 32.42% |
| 2028 | $186b | 14.17% |
| 2029 | $233b | 25.32% |
EBITDA Margin
| 2025 | 64.30% | 11.60% |
|---|---|---|
| 2026 | 61.35% | 4.60% |
| 2027 | 64.90% | 5.79% |
| 2028 | 64.75% | 0.23% |
| 2029 | 74.36% | 14.84% |
29 NVIDIA Analysts have issued a net profit forecast 2026. The average NVIDIA net profit estimate is $100.0b . This is 30.22% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $130b 69.31% , the lowest is $90.0b 17.22% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $72.9b | 144.89% |
|---|---|---|
| 2026 | $100.0b | 37.18% |
| 2027 | $134b | 34.00% |
| 2028 | $156b | 16.20% |
Net Margin
| 2025 | 55.85% | 14.33% |
|---|---|---|
| 2026 | 49.87% | 10.70% |
| 2027 | 53.38% | 7.04% |
| 2028 | 54.20% | 1.54% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
29 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA EPS is $4.10 . This is 32.26% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.33 71.94% , the lowest is $3.69 19.03% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $2.94 | 147.06% |
|---|---|---|
| 2026 | $4.10 | 39.46% |
| 2027 | $5.49 | 33.90% |
| 2028 | $6.38 | 16.21% |
P/E ratio
| Current | 45.80 | 35.22% |
|---|---|---|
| 2026 | 34.63 | 24.38% |
| 2027 | 25.85 | 25.35% |
| 2028 | 22.24 | 13.97% |
Based on analysts' sales estimates for 2026, the NVIDIA stock is valued at an EV/Sales of 17.05 and an P/S ratio of 17.28 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 23.02 | 37.80% |
|---|---|---|
| 2026 | 17.05 | 25.92% |
| 2027 | 13.62 | 20.12% |
| 2028 | 11.90 | 12.61% |
| 2029 | 10.91 | 8.36% |
| 2030 | 10.56 | 3.23% |
P/S ratio
| Current | 23.32 | 37.43% |
|---|---|---|
| 2026 | 17.28 | 25.92% |
| 2027 | 13.80 | 20.12% |
| 2028 | 12.06 | 12.61% |
| 2029 | 11.05 | 8.36% |
| 2030 | 10.70 | 3.23% |
Current NVIDIA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Overweight
➜
Overweight
|
Unchanged | May 29 2025 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | May 29 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | May 29 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | May 29 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 29 2025 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
May 29 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
May 29 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
May 29 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
May 29 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
May 29 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
May 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
